<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fried, Michael W</style></author><author><style face="normal" font="default" size="100%">Shiffman, Mitchell L</style></author><author><style face="normal" font="default" size="100%">Reddy, K Rajender</style></author><author><style face="normal" font="default" size="100%">Smith, Coleman</style></author><author><style face="normal" font="default" size="100%">Marinos, George</style></author><author><style face="normal" font="default" size="100%">Gonçales Jr, Fernando L</style></author><author><style face="normal" font="default" size="100%">Häussinger, Dieter</style></author><author><style face="normal" font="default" size="100%">Diago, Moises</style></author><author><style face="normal" font="default" size="100%">Carosi, Giampiero</style></author><author><style face="normal" font="default" size="100%">Dhumeaux, Daniel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</style></title><secondary-title><style face="normal" font="default" size="100%">New England Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2002</style></year></dates><publisher><style face="normal" font="default" size="100%">Mass Medical Soc</style></publisher><volume><style face="normal" font="default" size="100%">347</style></volume><pages><style face="normal" font="default" size="100%">975-982</style></pages><isbn><style face="normal" font="default" size="100%">0028-4793</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">13</style></issue></record></records></xml>